


Pfizer Tokenized Stock (Ondo), known by its abbreviation PFEON, represents a tokenized version of Pfizer stocks. It offers tokenholders economic exposure reminiscent of directly holding Pfizer shares, including the reinvestment of any dividends. This innovation by Ondo enables users around the globe to mint and redeem tokenized US stocks and ETFs 24/5, with seamless access to traditional exchange liquidity. This initiative is particularly beneficial for non-US retail and institutional users, enhancing inclusivity in the global financial market.
The PFEON token operates by mirroring the performance of Pfizer's actual stock. When users purchase PFEON, they are essentially buying a digital representation of Pfizer shares. The tokens are backed by equivalent shares held in custody, ensuring that the digital asset faithfully tracks the stock's market movements. This mechanism allows users to gain exposure to Pfizer's financial performance without the need for a traditional brokerage account.
PFEON tokens can be used for various purposes, most notably for gaining exposure to the pharmaceutical giant Pfizer's financial performance. Investors can hold the tokens as part of a diversified portfolio, or trade them to leverage market movements. Additionally, tokenholders benefit from any dividends, which are reinvested back into the token, reflecting the stockholder's returns. This utility makes PFEON a versatile asset for engaging with Pfizer in the digital economy.
To purchase Pfizer Tokenized Stock (Ondo), interested buyers can learn how to buy Pfizer Tokenized Stock (Ondo) on platforms like WEEX. The buying process typically involves setting up an account on a platform that supports tokenized stocks, such as WEEX, where PFEON can be traded against various pairs like USDT. Once registered or logged in, users can conduct trades by placing buy orders within the platform's interface, taking advantage of WEEX's comprehensive trading tools.
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼Deribit's monopoly position is loosening, with Bybit's share jumping to second globally.